Sycai Medical funding news – Barcelona-based Sycai Medical secures €3M in Funding

The money will help develop and launch their AI-driven medical device, which uses medical imaging to detect early-stage cancer and pre-cancerous lesions in the abdomen, avoiding the need for invasive procedures.

The technology focuses on improving early detection of deadly cancers like pancreatic, kidney, and liver cancers, which are often diagnosed too late.

Sven Bakkes, founding partner of LUMO Labs, says, “Eary diagnosis and targeted cures are key for the quality of life of a patient but also improve the circumstances for caregivers and even the efficiency of how our healthcare system is organised. We have looked at similar research and technologies across Europe and concluded that the accuracy, hardware-agnostic approach, and scalability of Sycai Medical is unmatched.”

Jorge Blasco, Partner at LUMO Labs for Spain and Portugal, adds, “Also the commitment and drive of the team is exceptional. From the very start of the development of the product they were present directly in hospitals and listening to doctors and patients non-stop to make sure they were building something that really helps people. I am very much looking forward to working with them on behalf of LUMO here in Barcelona.”

The funds will help launch Sycai Medical’s approved digital device in Europe, expand its capabilities to detect liver and kidney lesions as well as pancreatic lesions, and work on getting FDA approval in the US.

Read also - VitVio funding news – London-based VitVio has Secured €1.8 Million in Pre-Seed Funding

Sara Toledano, Sycai CEO and co-founder, says, “Successfully completing this investment round marks a significant milestone for us at a very strategic moment in the company’s evolution. We are currently undergoing a transformation from a product-driven to a business-driven organisation, due to the MDR approval and initiation of commercial activities. We are confident that our new investors will play a pivotal role in fostering a refreshed mindset to support this transition.”

About Sycai Medical

Sycai Medical was founded in 2020 by Sara Toledano, Javier García, and Júlia Rodríguez during the pandemic. The company uses technology to help doctors and patients. Based at Barcelona Activa, it creates tools to help radiologists and healthcare professionals diagnose abdominal cancer early. The product detects and tracks pre-malignant lesions before they become cancerous, and automates patient monitoring.